Rotella Capital Management, Inc. - SKYSTAR BIO-PHARMA CO ownership

Back to all holdings Add to watchlist

SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 11 filers reported holding SKYSTAR BIO-PHARMA CO in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of SKYSTAR BIO-PHARMA CO
ValueSharesWeighting
Q1 2015$70,000
-48.9%
18,026
-44.5%
0.06%
-50.4%
Q4 2014$137,000
-2.1%
32,493
-2.7%
0.12%
-19.0%
Q3 2014$140,000
+10.2%
33,393
+93.1%
0.15%
+36.1%
Q2 2014$127,000–17,293–0.11%–
 Download
Other shareholders
SKYSTAR BIO-PHARMA CO shareholders Q3 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 147,926$141,0000.01%
Tower Research Capital LLC (TRC) 181$00.00%
HighTower Advisors, LLC 22,845$22,0000.00%
MORGAN STANLEY 11,593$11,0000.00%
BlackRock Institutional Trust Company, N.A. 175,708$167,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,900$15,0000.00%
Walleye Trading LLC 200$00.00%
Citadel Advisors 18,296$17,0000.00%
Renaissance Technologies 52,300$50,0000.00%
UBS Group AG 3,304$3,0000.00%
View complete list of SKYSTAR BIO-PHARMA CO shareholders